Partnership to Develop Companion Diagnostic Kit for Lymphoma
Foresight Diagnostics and QIAGEN have entered a global partnership to develop and commercialize a companion diagnostic kit for lymphoma.
Read MorePosted by Chris Wolski | Jun 4, 2025 | Lymphoma |
Foresight Diagnostics and QIAGEN have entered a global partnership to develop and commercialize a companion diagnostic kit for lymphoma.
Read MorePosted by Chris Wolski | Jun 4, 2025 | Cancer |
Guardant Health’s Shield MCD test has received FDA Breakthrough Device designation for its ability to detect multiple cancer types.
Read MorePosted by Chris Wolski | Jun 4, 2025 | Mass Spectrometry Instruments |
Thermo Fisher Scientific unveiled advanced mass spectrometry instruments—Orbitrap Astral Zoom MS and Orbitrap Excedion Pro MS.
Read MorePosted by Chris Wolski | Jun 3, 2025 | Molecular Diagnostics |
Seer, Inc. and Korea University have launched a groundbreaking, large-scale proteomics study using the Proteograph Platform.
Read MorePosted by Chris Wolski | May 30, 2025 | POC Instruments |
Researchers have developed a new bioluminescence-based diagnostic tool that offers virus detection in complex biological samples.
Read More